Eli Lilly and Company (NYSE: LLY) reported that its experimental obesity drug retatrutide demonstrated substantial weight loss in a pivotal ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE